CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,221 | +10002.7% | 65,608 | -35.4% | 0.00% | -100.0% |
| Q4 2022 | $1,091 | -99.6% | 101,544 | +210.5% | 0.00% | +300.0% |
| Q3 2022 | $306,000 | -29.3% | 32,700 | -31.0% | 0.00% | -50.0% |
| Q2 2022 | $433,000 | -95.9% | 47,398 | -93.5% | 0.00% | -94.3% |
| Q2 2021 | $10,446,000 | +653.1% | 732,041 | +1045.9% | 0.04% | +483.3% |
| Q1 2021 | $1,387,000 | +159.3% | 63,882 | +80.7% | 0.01% | +200.0% |
| Q4 2020 | $535,000 | -74.4% | 35,359 | -78.5% | 0.00% | -83.3% |
| Q3 2020 | $2,091,000 | +108.7% | 164,300 | +164.2% | 0.01% | +100.0% |
| Q4 2019 | $1,002,000 | – | 62,194 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |